⌘+K

Pulse Explore Communities Researchers Journals

Home Communities Explore

January 1, 2024Journal of Cellular ImmunologyOpen Access

Can Molecular Biomarkers be Utilized to Determine Appropriate Adjuvant Therapy in Early-Stage Non-Small Cell Lung Cancer (NSCLC)?

Prashanth Ashok Kumar Alina Basnet Stephen L. Graziano

View Full Paper

Ask AI

Bookmark

Share

Abstract

Early-stage NSCLC, encompassing resectable stage I-III [1] are curable, and represents 25% of all lung cancers [2]. The management of non-metastatic NSCLC is a rapidly changing area of clinical oncology.

Discussion

No takes yet. Share an insight, caveat, or question.

Cite This Study

Kumar et al. (2024) studied this question.

synapsesocial.com/papers/6a11d01b8b61bd91eb563e43 https://doi.org/10.33696/immunology.6.193

View Full Paper

Ask AI

Bookmark

Share

Keep reading

Synapse has enriched 5 related papers. Consider them for comparative context:

1A Commentary on Dual Orphan Nuclear Receptor 4A1 (NR4A1) and NR4A2 LigandsJournal of Cellular Immunology · Mon,
2VEGF-D Dependent IFNγ Production by Natural Killer Cells in LymphangioleiomyomatosisJournal of Cellular Immunology · Wed,
3Risk Factors of Chronic Spontaneous Urticaria with COVID-19 Vaccination: A Cross-Sectional StudyJournal of Cellular Immunology · Wed,
4Modeling TCIRG1 Neutropenia by Utilizing Patient Derived Induced Pluripotent Stem CellsJournal of Cellular Immunology · Wed,
5The Role of Innate Immune System: A Crosstalk between Invertebrates and HumansJournal of Cellular Immunology · Wed,

More from Journal of Cellular Immunology

From Bench to Body: Protective Candida-specific Monoclonal Antibodies Show In vivo and Translational PotentialWed,
Serum Cytokines During Acute Respiratory Infection and Relationship to AgeWed,
Personalized Neoantigen DNA Cancer Vaccines: Current Status and Future PerspectivesSat,
Essentials of CAR-T Therapy and Associated Microbial Challenges in Long Run ImmunotherapyMon,
Advances of Immune Cells in the Pathogenesis and Targeted Therapy of Systemic Lupus ErythematosusMon,